Cancer Research UK logo.
SearchDonate
  • Search

A trial of rituximab and varlilumab for people with B cell lymphoma (RiVa)

Overview

Cancer types:

Blood cancers, Cell type, High grade lymphoma, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 2

Details

This trial is for people with a type of lymphoma that affects the B cells (B cell lymphoma) that has either:

  • come back (relapsed)

  • continued to grow despite treatment (refractory)

It is for people who have a protein called CD20 on the surface of their lymphoma cells (CD20 positive).

Cancer Research UK supports this trial.

Recruitment start: 23 November 2017

Recruitment end: 31 December 2020

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Sean Hua Lim

Supported by

Cancer Research UK

University of Southampton

University Hospital Southampton NHS Foundation Trust

Other information

This is Cancer Research UK trial number CRUKD/17/008.

Last reviewed: 10 November 2022

CRUK internal database number: 14317

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.